CCDC88C, an O-GalNAc glycosylation substrate of GALNT6, drives breast cancer metastasis by promoting c-JUN-mediated CEMIP transcription

• Published in: Cancer cell international 2024-07, Vol.24 (1), p.237-15, Article 237
• Main Authors: Deng, Boya, Zhang, Siyang, Zhou, Yingying, Sun, Ting, Zhu, Ying, Fei, Jing, Li, Ailin, Miao, Yuan
• Format: Article
• Language: English
• Subjects: Antibodies; Breast cancer; c-Jun protein; CCDC88C; Cells; CEMIP; Cloning; Colorectal cancer; Colorectal carcinoma; Estrogens; GALNT6; Glycosylation; Hepatocytes; JUN; Laboratory animals; Lectins; Liver cancer; Lung cancer; Lymph nodes; Metastases; Metastasis; Molecular modelling; N-acetylgalactosaminyltransferase; Plasmids; Polypeptide N-acetylgalactosaminyltransferase; Proteins; Transcription activation; Transcription factors; Wnt protein
• ISSN: 1475-2867; 1475-2867
• DOI: 10.1186/s12935-024-03413-2

Coiled-coil domain containing 88C (CCDC88C) is a component of non-canonical Wnt signaling, and its dysregulation causes colorectal cancer metastasis. Dysregulated expression of CCDC88C was observed in lymph node metastatic tumor tissues of breast cancer. However, the role of CCDC88C in breast cancer metastasis remains unclear. To address this, the stable BT549 and SKBR3 cell lines with CCDC88C overexpression or knockdown were developed. Loss/gain-of-function experiments suggested that CCDC88C drove breast cancer cell motility in vitro and lung and liver metastasis in vivo. We found that CCDC88C led to c-JUN-induced transcription activation. Overlapping genes were identified from the genes modulated by CCDC88C and c-JUN. CEMIP, one of these overlapping genes, has been confirmed to confer breast cancer metastasis. We found that CCDC88C regulated CEMIP mRNA levels via c-JUN and it exerted pro-metastatic capabilities in a CEMIP-dependent manner. Moreover, we identified the CCDC88C as a substrate of polypeptide N-acetylgalactosaminyltransferase 6 (GALNT6). GALNT6 was positively correlated with CCDC88C protein abundance in the normal breast and breast cancer tissues, indicating that GALNT6 might be associated with expression patterns of CCDC88C in breast cancer. Our data demonstrated that GALNT6 maintained CCDC88C stability by promoting its O-linked glycosylation, and the modification was critical for the pro-metastatic potential of CCDC88C. CCDC88C also could mediate the pro-metastatic potential of GALNT6 in breast cancer. Collectively, our findings uncover that CCDC88C may increase the risk of breast cancer metastasis and elucidate the underlying molecular mechanisms.